Skip to content
Valuing Early Stage Life Science Companies to Optimize Partnership and Other TransactionsRBCx2025-04-02T11:14:26-04:00
Navigating Venture DebtRBCx2025-03-05T11:07:25-05:00
A Fireside Chat on Entrepreneurship and Leadership with RBCx and MinervaRBCx2025-04-04T11:10:27-04:00
Unpacking a Decade of VC Fundraising ActivityRBCx2024-08-19T10:30:13-04:00
Science for CFOsRBCx2024-11-07T13:21:08-05:00
The Art and Science of Valuations – How Your Capital Stack Stacks UpRBCx2024-04-18T15:32:17-04:00
Surviving a Bear Market with Anthony Mouchantaf, Former Head of Capital, RBCxRBCx2024-04-18T15:23:29-04:00
Straight from the Source – Market Insights from RBCx and CartaRBCx2024-03-18T11:49:33-04:00
Navigating Venture Debt | What Canadian Founders Should Be Thinking AboutRBCx2025-04-02T11:53:27-04:00
How Monetary Policy is impacting Canadian VCs and StartupsRBCx2024-03-18T12:24:39-04:00
Page load link
